Key result
Elevated ACE gene expression is linked to ~12.1-fold higher odds of obesity-related hypertension.
Why the study?
Obesity and hypertension frequently coexist and increase CVD risk through interrelated endocrine, inflammatory, and vascular pathways. This study evaluated selected biochemical, thyroid, inflammatory, and genetic markers, particularly ACE gene expression, in individuals with obesity-associated hypertension.
Are ACE gene expression, inflammatory biomarkers (hs-CRP, IL-6), and thyroid-stimulating hormone (TSH) independently associated with obesity-related hypertension in adults aged 25–55 years?
Case-Control (n=360)
No
Are ACE gene expression, inflammatory biomarkers (hs-CRP, IL-6), and thyroid-stimulating hormone (TSH) independently associated with obesity-related hypertension in adults aged 25–55 years?
Upregulated ACE gene expression and elevated hs-CRP are strongly associated with obesity-related hypertension and correlate with systemic inflammatory burden, highlighting synergistic RAS and inflammatory activation in hypertensive obesity.
Answers are grounded in this paper and cite their sources.
ACE expression may support biomarker research in obesity-related hypertension; leaves open prospective validation before any clinical use.
Obesity and hypertension frequently coexist and together increase cardiovascular disease (CVD) risk through interrelated endocrine, inflammatory, and vascular pathways. The aim – evaluated selected biochemical, thyroid, inflammatory, and genetic markers, with a particular focus on angiotensin-converting enzyme (ACE) gene expression, in individuals with obesity-associated hypertension.Materials and methods. A case-control design was used, including 360 participants (180 hypertensive-obese cases and 180 normotensive controls). Fasting blood samples were analyzed for thyroid-stimulating hormone (TSH), high-sensitivity C-reactive protein (hs-CRP), interleukin-6 (IL-6), and ACE gene expression quantified using the 2–ΔΔCt method, along with routine metabolic, renal, and cardiac parameters. Group differences were assessed using non-parametric tests. Receiver operating characteristic (ROC) curves were constructed to evaluate diagnostic performance, and multivariable logistic regression was applied to identify independent predictors of obesity-related hypertension. Correlation and linear regression analyses were used to examine factors influencing ACE gene expression.Results. Individuals with hypertensive obesity showed significantly higher levels of TSH, hs-CRP, IL-6, and ACE gene expression compared with controls. ACE gene expression demonstrated the greatest discriminatory ability on ROC analysis (AUC 0.86). Significant positive correlations were observed between ACE gene expression and both hs-CRP and IL-6. In regression analysis, ACE gene expression, hs-CRP, and IL-6 emerged as independent predictors, with ACE gene expression showing the strongest association.Conclusions. Obesity-hypertension is characterized by heightened inflammatory activity, endocrine alterations, and increased ACE gene expression. ACE gene expression may have potential value for identifying individuals at elevated cardiometabolic risk, although further longitudinal studies are needed to confirm its clinical relevance.
No takes yet. Share an insight, caveat, or question.
Mohanan et al. (2026) conducted a case-control in Obesity-associated hypertension (n=360). ACE gene expression (2−ΔΔCt) vs. Healthy normotensive controls with normal BMI was evaluated on Obesity-associated hypertension (hypertensive-obese status) (OR 12.131, 95% CI 1.303-112.984, p=0.028). ACE gene expression was elevated in hypertensive-obese individuals and independently predicted obesity-related hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: